glp 1 and sleep apnea Therapeutic potential of GLP-1RAs in with genetic associations to type 2 diabetes | Diabetology & Metabolic Syndrome Latest Insights on GLP-1 Therapy

Independent of breast cancer mortality, obesity increases the risk of comorbid conditions, including cardiovascular disease (the most common cause of noncancerrelated death in breast cancer patients) and diabetes

Nat Rev Endocrinol 19 , 201216 (2023)

This notion was confirmed using metabolic cages, revealing that GLP-1MK-801 counteracted the decrease in energy expenditure that is engaged by calorie-restricted mammals as an adaptive starvation response to protect the organism from an excessive loss of body weight and fat mass (Fig

doi:10.1111/obr.13841 27

From a scientific perspective, exenatides approval proved the validity of GLP-1 receptor agonism as a therapeutic strategy ( [99] ) ( [100] )

This medication works by mimicking the action mechanism of natural insulin, contributing to appetite regulation, slowing gastric emptying, and improving glycemic control